221 related articles for article (PubMed ID: 10443649)
1. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome.
N'Diaye N; Hamet P; Tremblay J; Boutin JM; Gaboury L; Lacroix A
J Clin Endocrinol Metab; 1999 Aug; 84(8):2616-22. PubMed ID: 10443649
[TBL] [Abstract][Full Text] [Related]
2. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH.
Croughs RJ; Zelissen PM; van Vroonhoven TJ; Hofland LJ; N'Diaye N; Lacroix A; de Herder WW
Clin Endocrinol (Oxf); 2000 Feb; 52(2):235-40. PubMed ID: 10671952
[TBL] [Abstract][Full Text] [Related]
3. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
[TBL] [Abstract][Full Text] [Related]
4. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells.
de Herder WW; Hofland LJ; Usdin TB; de Jong FH; Uitterlinden P; van Koetsveld P; Mezey E; Bonner TI; Bonjer HJ; Lamberts SW
J Clin Endocrinol Metab; 1996 Sep; 81(9):3168-72. PubMed ID: 8784063
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R
N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608
[TBL] [Abstract][Full Text] [Related]
6. Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results.
Albiger NM; Occhi G; Mariniello B; Iacobone M; Favia G; Fassina A; Faggian D; Mantero F; Scaroni C
Eur J Endocrinol; 2007 Dec; 157(6):771-8. PubMed ID: 18057385
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
[TBL] [Abstract][Full Text] [Related]
8. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis.
Chabre O; Liakos P; Vivier J; Chaffanjon P; Labat-Moleur F; Martinie M; Bottari SP; Bachelot I; Chambaz EM; Defaye G; Feige JJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3134-43. PubMed ID: 9745416
[TBL] [Abstract][Full Text] [Related]
10. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.
Lampron A; Bourdeau I; Hamet P; Tremblay J; Lacroix A
J Clin Endocrinol Metab; 2006 Sep; 91(9):3611-8. PubMed ID: 16772347
[TBL] [Abstract][Full Text] [Related]
11. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?
Swords FM; Aylwin S; Perry L; Arola J; Grossman AB; Monson JP; Clark AJ
J Clin Endocrinol Metab; 2005 May; 90(5):3009-16. PubMed ID: 15705925
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
Bertherat J; Contesse V; Louiset E; Barrande G; Duparc C; Groussin L; Emy P; Bertagna X; Kuhn JM; Vaudry H; Lefebvre H
J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
[TBL] [Abstract][Full Text] [Related]
13. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.
Groussin L; Perlemoine K; Contesse V; Lefebvre H; Tabarin A; Thieblot P; Schlienger JL; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 May; 87(5):1980-5. PubMed ID: 11994328
[TBL] [Abstract][Full Text] [Related]
14. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
Lacroix A; Tremblay J; Touyz RM; Deng LY; Lariviere R; Cusson JR; Schiffrin EL; Hamet P
J Clin Endocrinol Metab; 1997 Aug; 82(8):2414-22. PubMed ID: 9253310
[TBL] [Abstract][Full Text] [Related]
15. Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion.
Pralong FP; Gomez F; Guillou L; Mosimann F; Franscella S; Gaillard RC
J Clin Endocrinol Metab; 1999 Oct; 84(10):3817-22. PubMed ID: 10523036
[TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
Iida K; Kaji H; Matsumoto H; Okimura Y; Abe H; Fujisawa M; Kamidono S; Chihara K
Clin Endocrinol (Oxf); 1997 Dec; 47(6):739-45. PubMed ID: 9497882
[TBL] [Abstract][Full Text] [Related]
17. Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome.
Preumont V; Mermejo LM; Damoiseaux P; Lacroix A; Maiter D
Horm Metab Res; 2011 Apr; 43(4):287-91. PubMed ID: 21264796
[TBL] [Abstract][Full Text] [Related]
18. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.
Lecoq AL; Stratakis CA; Viengchareun S; Chaligné R; Tosca L; Deméocq V; Hage M; Berthon A; Faucz FR; Hanna P; Boyer HG; Servant N; Salenave S; Tachdjian G; Adam C; Benhamo V; Clauser E; Guiochon-Mantel A; Young J; Lombès M; Bourdeau I; Maiter D; Tabarin A; Bertherat J; Lefebvre H; de Herder W; Louiset E; Lacroix A; Chanson P; Bouligand J; Kamenický P
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931750
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
de Miguel V; Redal MA; Viale ML; Kahan M; Glerean M; Beskow A; Fainstein Day P
Medicina (B Aires); 2010; 70(3):254-6. PubMed ID: 20529775
[TBL] [Abstract][Full Text] [Related]
20. An adolescent with food-dependent Cushing's syndrome secondary to ectopic expression of GIP receptor in unilateral adrenal adenoma.
Noordam C; Hermus AR; Pesman G; N'Diaye N; Sweep CG; Lacroix A; Otten BJ
J Pediatr Endocrinol Metab; 2002 Jun; 15(6):853-60. PubMed ID: 12099397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
